Upon SEC approval of the amended Form 10, BioStem expects to advance its uplisting to NasdaqPOMPANO BEACH, Fla., June 03, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (“BioStem” or the ...

Learn about the Form 10-K with our beginner's guide. Explore what it reveals about a company's financial health, operations, and future prospects.

The Company initially submitted its Form 10 in September 2024 and has worked closely with its auditors and the SEC throughout the review process including to address questions regarding the ...